JENNIFER BACCI: Open Payments
NPI 1225625122 · EDISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,603 in 85 payments from 18 companies in 2025. Trend: 2023 $222 · 2024 $584 · 2025 $1,603
Food & beverage: $1,603
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 19 | $348 |
| ABBVIE INC. | 13 | $296 |
| Janssen Biotech, Inc. | 14 | $266 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $108 |
| Ardelyx, Inc. | 5 | $97 |
| Lilly USA, LLC | 5 | $86 |
| GENZYME CORPORATION | 4 | $75 |
| QOL Medical, LLC | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Ipsen Biopharmaceuticals, Inc | 3 | $52 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, IBSRELA, DUPIXENT, OMVOH, Sucraid, LINZESS.
Industry payments across NJ — which companies pay providers there.
